NCT06687421View on ClinicalTrials.gov

Implementation of Precision Medicine in High-risk Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

5,500

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

December 31, 2054

Study Completion Date

December 31, 2054

Conditions
Prostate Cancer
Interventions
OTHER

High-risk treatment SOC

radiotherapy (RT) + ADT (3 years) + Abiraterone acetate (2 years), with radical prostatectomy being an option if contraindication for RT exists)

OTHER

Active monitoring

Followed with PSA measurements

PROCEDURE

Radical prostatectomy

Radical prostatectomy

RADIATION

Radiotherapy

Radiotherapy

DRUG

Androgen deprivation therapy

GnRH agonist + abiraterone acetate/enzalutamide and/or docetaxel

Trial Locations (1)

901 85

RECRUITING

Urology, Umeå University Hospital, Region Västerbotten, Umeå

All Listed Sponsors
collaborator

Umeå University

OTHER

lead

Andreas Josefsson

OTHER_GOV